NCT05259202

Brief Summary

ST-analysis of the foetal ECG (STAN®) is another second line technique for intrapartum foetal monitoring. Combining ST-analysis with standard CTG interpretation aims to identify hypoxic foetuses more accurately than CTG alone. The STAN® method identifies changes in the ST-interval of the foetal ECG that occur in the presence of foetalcentral hypoxia The aim of this studie is to investigate if the foetal lactate blood sampling is still useful when STAN® monitoring is already being used as a second line technique for intrapartum foetal monitoring if the fetal heart rate is abnormal without a significant ST event Nowadays in the Montpellier hospital's protocol, the investigators have to check the value of lactate sampling in case of le STAN doesn't detect an ST event. So this studie can change the Montpellier hospital's protocol and avoid useless fetal blood sampling

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2022

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

February 17, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 28, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2022

Completed
Last Updated

February 28, 2022

Status Verified

February 1, 2022

Enrollment Period

3 months

First QC Date

February 17, 2022

Last Update Submit

February 17, 2022

Conditions

Keywords

serious metabolic acidosisT segment analysisBlood samplesinstrumental deliveryApgar scoreadmission to a neonatal ward

Outcome Measures

Primary Outcomes (1)

  • the incidence of serious metabolic acidosis

    the incidence of serious metabolic acidosis (defined as pH \< 7 and Bdecf \> 12 mmol/L in the umbilical cord artery).

    day 1

Secondary Outcomes (2)

  • Number of the instrumental delivery

    day 1

  • Number of the neonatal outcome

    day 1

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

women monitored by STAN in active labour with singleton term fetus in cephalic presentation

You may qualify if:

  • patient with labor monitoring by ST segment analysis (STAN) according to current guidelines
  • patient who received a fetal lactate sample for fetal heart rate classified as pathological for more than 60 minutes

You may not qualify if:

  • STAN guidelines not respected before installation and during work
  • misclassification of fetal heart rate
  • obstetrical complications during labor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

RECRUITING

MeSH Terms

Conditions

Acidosis

Condition Hierarchy (Ancestors)

Acid-Base ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • WALTZING Aude

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Central Study Contacts

WALTZING Aude, Resident

CONTACT

DUPORT-PERCIER Marie, MD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 17, 2022

First Posted

February 28, 2022

Study Start

February 1, 2022

Primary Completion

May 1, 2022

Study Completion

October 31, 2022

Last Updated

February 28, 2022

Record last verified: 2022-02

Locations